Jefferies Financial Group Inc (JEF) concluded trading on Thursday at a closing price of $56.09, with 4.39 million shares of worth about $246.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -26.41% during that period and on June 26, 2025 the price saw a gain of about 0.30%. Currently the company’s common shares owned by public are about 206.27M shares, out of which, 164.19M shares are available for trading.
Stock saw a price change of 5.39% in past 5 days and over the past one month there was a price change of 12.72%. Year-to-date (YTD), JEF shares are showing a performance of 21.04% which decreased to -28.46% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $39.28 but also hit the highest price of $82.68 during that period. The average intraday trading volume for Jefferies Financial Group Inc shares is 1.92 million. The stock is currently trading 7.10% above its 20-day simple moving average (SMA20), while that difference is up 12.20% for SMA50 and it goes to -10.95% lower than SMA200.
Jefferies Financial Group Inc (NYSE: JEF) currently have 206.27M outstanding shares and institutions hold larger chunk of about 69.98% of that.
The stock has a current market capitalization of $11.57B and its 3Y-monthly beta is at 1.45. PE ratio of stock for trailing 12 months is 21.23, while it has posted earnings per share of $2.64 in the same period. Its PEG reads 0.91 and has Quick Ratio of 1.46 while making debt-to-equity ratio of 3.40. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for JEF, volatility over the week remained 3.45% while standing at 2.84% over the month.
Stock’s fiscal year EPS is expected to drop by -19.18% while it is estimated to increase by 75.45% in next year. EPS is likely to grow at an annualized rate of 23.45% for next 5-years, compared to annual growth of -0.32% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on April 07, 2025 offering an Equal-weight rating for the stock and assigned a target price range of between $75 and $41 to it. On December 09, 2024, Morgan Stanley Upgrade their recommendations, while on September 17, 2024, UBS Initiated their ratings for the stock with a price target of $67. Stock get a Buy rating from Goldman on August 22, 2023.
